Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline vs Doxycycline for Scrub Typhus
NCT07513103Completed
- Start
- Nov 2022
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of tigecycline in scrub typhus (2 arms). Primary endpoint: Time to Defervescence at Day 7. Started Nov 2022; status: completed.
02
Drugs
tigecycline
03
Conditions
scrub typhus
Beyond the preview
Go deeper on NCT07513103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07513103.